Sentence examples for chronic left ventricular dysfunction from inspiring English sources

In a retrospective analysis [42], warfarin use in patients with heterogeneous causes of chronic left ventricular dysfunction demonstrated improved survival and risk of hospitalization for heart failure, but had no effect on stroke.

Therefore, autoimmunity against the second extracellular loop of the β1AR is considered a cause or cofactor of chronic left ventricular dysfunction and a potential therapy target.

The SEARCH-MI registry is a European multi-centre, prospective, observational study enrolling patients after myocardial infarction, chronic left ventricular dysfunction and an ICD implanted for primary prevention of sudden death.

Despite these inconsistencies, the paradigm of Chagas' cardiomyopathy in conjunction with the available results of experimental immunizations build a reasonably strong case for autoantibodies against the second extracellular loop domain of the human β1-adrenoceptor as a specific pathogen in chronic left ventricular dysfunction.

Clinical guidelines recommend implantable cardioverter-defibrillators (ICDs) for selected patients with chronic left ventricular dysfunction (LVD) to improve survival, yet ICD treatment rates for eligible patients with LVD or heart failure (HF) in cardiology practices remain poorly studied.

Trachtenberg, B. et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.

In conclusion, such autoantibodies seem to cause or promote chronic human left ventricular dysfunction by acting on their receptor targets in a drug-like fashion.

For patients with chronic AF and left ventricular dysfunction, direct current cardioversion is the preferred conversion method.

In the screening phase of this study all patients with chronic (> 6 months) left ventricular dysfunction (EF ≥30%to≤55%5%) combined with persistent clinical symptoms of heart failure (NYHA II and NYHA III) after exclusion of coronary heart disease were enrolled.

Hager et al. compared death at 1 year in 958 patients with chronic kidney disease, who had undergone ICD placement, and concluded that the mortality rate at 1 year increases with worsening chronic kidney disease and if left ventricular dysfunction was present [ 3].

Pregnancy is usually well tolerated in women with chronic left sided valve regurgitation without left ventricular dysfunction.